Federica Ricceri

9PUBLICATIONS
23CO-AUTHORS
PharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityErgonomics designClinical social work practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 11, 2024
Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort study.

Andrea Chiricozzi, Giulia Coscarella, Luis Puig

|Aug 29, 2022
Successful use of anti-IL-23 molecules in overweight-to-obese psoriatic patients: A multicentric retrospective study.

Federica Ricceri, Andrea Chiricozzi, Ketty Peris

|Oct 08, 2020
Clinical experience with adalimumab biosimilar imraldi in hidradenitis suppurativa.

Federica Ricceri, Elia Rosi, Antonella Di Cesare

|Apr 20, 2020
SB5 adalimumab biosimilar in the treatment of psoriasis and psoriatic arthritis.

Antonella Di Cesare, Greta Tronconi, Thais M Fastame

|Dec 06, 2018
Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa.

Elia Rosi, Leonardo Pescitelli, Federica Ricceri

|Sep 14, 2018
First case of secukinumab successful therapy in a very elderly psoriatic patient.

F Ricceri, L Pescitelli, L Lazzeri

Pageof 2